Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Posted on by ScienceFather

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

​As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Geriatrician at OHSU, United States

Dr. E. Foy White-Chu, MD, CWSP, AGSF, is a distinguished geriatrician and wound care specialist at the VA Portland Health Care System (VAPHCS), where she serves as the Geriatric Fellowship Director and Wound Medical Director. She holds an Associate Professorship at Oregon Health & Science University and has extensive experience in geriatrics, wound care, and medical education. Dr. White-Chu has contributed significantly to the field through research, policy initiatives, and curriculum development, securing multiple grants for interdisciplinary wound care education. She has held leadership roles in professional organizations, including the Wound Healing Society and the American Geriatrics Society, and has served on national advisory committees. Her research, focusing on chronic wound care and skin failure in older adults, has been widely published in leading medical journals. Recognized with numerous awards, including Portland’s Top Doctors, she continues to shape healthcare practices through innovation, education, and evidence-based clinical advancements.

Professional Profile 

Education

Dr. E. Foy White-Chu earned her Doctor of Medicine (MD) degree from Baylor College of Medicine, where she developed a strong foundation in geriatric medicine and wound care. She then pursued a residency in Internal Medicine at the University of Texas Southwestern Medical Center, refining her clinical expertise in managing complex medical conditions. Driven by her passion for elderly care, she completed a Geriatrics Fellowship at the University of Texas Health Science Center at San Antonio, gaining specialized training in aging-related health issues, chronic wound care, and interdisciplinary care models. Throughout her education, Dr. White-Chu demonstrated a commitment to academic excellence, research, and medical education, laying the groundwork for her leadership in geriatric medicine. Her advanced training has enabled her to integrate evidence-based practices into clinical care, education, and policy development, contributing significantly to improving healthcare outcomes for older adults, particularly in chronic wound management and skin integrity preservation.

Professional Experience

Dr. E. Foy White-Chu is a distinguished geriatrician with extensive experience in clinical care, research, and medical education. She has held key positions in academic and healthcare institutions, specializing in geriatrics, wound care, and dermatological conditions in older adults. As an attending physician, she has provided expert care for elderly patients, focusing on chronic wound management and skin integrity. Her leadership roles have included faculty appointments where she has mentored medical students, residents, and fellows in geriatric medicine. Dr. White-Chu has contributed significantly to advancing wound care practices, integrating evidence-based approaches into clinical protocols. She has also been actively involved in research, publishing studies on pressure ulcers, dermatological health in aging populations, and best practices for geriatric care. Her dedication extends to policy advocacy, where she works to enhance healthcare standards for older adults. Through her expertise, she continues to shape the future of geriatric medicine and wound care.

Research Interest

Dr. E. Foy White-Chu’s research interests center on geriatrics, dermatology in aging populations, and wound care management. She is particularly focused on pressure ulcers, chronic wound healing, and skin integrity in elderly patients. Her work explores innovative approaches to preventing and treating wounds, emphasizing evidence-based interventions to improve patient outcomes. Dr. White-Chu also investigates the intersection of dermatological health and aging, studying conditions such as xerosis, pruritus, and other skin disorders prevalent in older adults. Additionally, she is committed to advancing geriatric care through research on best practices in long-term care settings, addressing quality-of-life concerns and improving healthcare protocols for aging populations. Her studies contribute to policy development and clinical guidelines, ensuring that older adults receive optimal care. Through her research, she continues to influence advancements in geriatric dermatology and wound management, bridging the gap between medical science and practical healthcare applications for the elderly.

Award and Honor

Dr. E. Foy White-Chu has received numerous awards and honors in recognition of her contributions to geriatrics, dermatology, and wound care management. Her dedication to improving skin integrity in aging populations has earned her accolades from professional medical associations and research institutions. She has been recognized for her excellence in clinical practice, innovative research, and leadership in geriatric healthcare. Dr. White-Chu has received distinguished service awards for her efforts in advancing wound care treatment and pressure ulcer prevention. Additionally, she has been honored for her contributions to medical education, mentoring future healthcare professionals, and enhancing best practices in long-term care settings. Her work has also been acknowledged through invitations to speak at national and international conferences, where she shares her expertise on geriatric dermatology and wound management. Through these honors, Dr. White-Chu’s impact on aging healthcare continues to be recognized and celebrated within the medical community.

Research Skill

Dr. E. Foy White-Chu possesses exceptional research skills, particularly in the fields of geriatrics, dermatology, and wound care. Her expertise lies in conducting clinical studies focused on skin integrity, pressure ulcer prevention, and advanced wound healing techniques in elderly patients. She has a strong background in designing and implementing evidence-based research methodologies, analyzing clinical data, and translating findings into practical healthcare solutions. Dr. White-Chu is skilled in interdisciplinary collaboration, working closely with healthcare professionals, researchers, and policymakers to enhance patient outcomes. Her ability to critically evaluate medical literature and contribute to peer-reviewed publications demonstrates her analytical and scientific writing proficiency. Additionally, she has experience in securing research funding, developing grant proposals, and leading innovative projects in aging-related skin care. Through her rigorous research approach, she continues to advance the understanding of geriatric dermatology, improving the quality of life for elderly individuals with chronic skin conditions.

Conclusion

Dr. E. Foy White-Chu is a highly accomplished researcher in geriatric medicine and wound care, with a strong academic, clinical, and research background. She is well-qualified for the Best Researcher Award, particularly in the domain of geriatric healthcare and wound management. Strengthening international collaborations, expanding research scope to include emerging technologies, and securing larger research grants could further enhance her competitiveness for this prestigious recognition.

Publications Top Noted

Title: Healing a Gap in Medical Education: Efficacy of a Wound Care Didactic Intervention
Authors: Sarah L. Becker, Elizabeth Foy White-Chu, Elena Paz Munoz, Martha A. Oberg, Alex Gerardo Ortega-Loayza
Year: 2025
Citations: 0

Lars Blønd | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Lars Blønd | Medicine and Dentistry | Best Researcher Award

Senior Surgeon at Senior Surgeon, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon and researcher specializing in patellofemoral surgery. As the inventor of the Arthroscopic Deepening Trochleoplasty, he has made groundbreaking contributions to knee and shoulder arthroscopy. With over 40 peer-reviewed publications, book chapters, and a dedicated book on femoral trochlear dysplasia, his research has significantly impacted the field. He has held leadership roles, including President of the Danish Association of Sports Medicine and ESSKA Scientific Committee member, demonstrating his influence in orthopedic research. Additionally, he actively educates and trains surgeons worldwide through live surgeries and instructional courses. His work bridges clinical practice and research, ensuring direct patient care improvements. While expanding his multidisciplinary collaborations could enhance his impact, his dedication to advancing orthopedic surgery and mentoring the next generation of researchers makes him a highly deserving candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Lars Blønd’s educational journey reflects his commitment to excellence in medicine and orthopedic surgery. He graduated from gymnasium in 1981 before serving in the Danish Navy in 1982. He then pursued medical studies at the University of Copenhagen, earning his medical degree in 1991. Following this, he underwent extensive postgraduate training in orthopedic surgery across eight different hospitals between 1991 and 2002, ultimately becoming a certified specialist in orthopedic surgery in 2001. Furthering his expertise, he obtained a Certificate in Sports Medicine in 2003. His education laid the foundation for his specialization in arthroscopic surgery, particularly in knee and shoulder procedures. Throughout his career, Dr. Blønd has continued to refine his skills, engage in research, and contribute to advancements in patellofemoral surgery. His rigorous training, combined with years of hands-on experience, has established him as a leading figure in orthopedic surgery and medical education.

Professional Experience

Dr. Lars Blønd has an extensive and distinguished career in orthopedic surgery, specializing in arthroscopic procedures for the knee and shoulder. Since 2013, he has served as a senior surgeon at The Zealand University Hospital of Koege and Aleris Hospital while also working with the Danish Patient Safety Authority. Previously, he held leadership roles, including Chief Surgeon at GHP (2008–2013), Herlev University Hospital (2006–2008), and Gentofte University Hospital (2004–2006). His expertise extends to private healthcare, having worked as a consultant and chief surgeon at multiple private hospitals. Beyond clinical practice, he has contributed to sports medicine, serving as a team physician for the Superliga soccer team HB Køge FC. As an international educator, he has trained surgeons globally through live surgeries and instructional courses. His decades-long experience, leadership in orthopedic advancements, and dedication to patient care make him a highly respected figure in the field of orthopedic surgery.

Research Interest

Dr. Lars Blønd’s research primarily focuses on orthopedic surgery, with a strong emphasis on patellofemoral instability, knee biomechanics, and arthroscopic surgical techniques. He is widely recognized for his pioneering work in Arthroscopic Deepening Trochleoplasty, a procedure he developed to address trochlear dysplasia and recurrent patellar dislocations. His research explores innovative surgical methods to improve patient outcomes, including MPFL reconstruction, cartilage preservation, and treatment strategies for chronic anterior knee pain. Additionally, he has contributed to studies on sports-related injuries, exsanguination techniques, and advanced imaging for knee pathology assessment. His work also extends to regenerative medicine, particularly the use of adipose-derived stem cells for treating osteoarthritis. Through his numerous peer-reviewed publications, book chapters, and global conference presentations, Dr. Blønd has significantly advanced the understanding and treatment of knee conditions, making his research invaluable to the fields of orthopedic surgery and sports medicine.

Award and Honor

Dr. Lars Blønd has earned widespread recognition for his contributions to orthopedic surgery, particularly in the field of patellofemoral instability and arthroscopic procedures. While specific awards and honors are not explicitly listed, his leadership roles and memberships in esteemed medical societies, such as ESSKA and the Danish Society for Arthroscopic Surgery, highlight his influence and respect in the field. His pioneering work in developing the Arthroscopic Deepening Trochleoplasty technique has garnered international recognition, leading to invitations for live surgical demonstrations and educational courses worldwide. Additionally, his extensive contributions to medical literature, including over 40 peer-reviewed publications and multiple book chapters, demonstrate his scholarly impact. As a sought-after speaker at global conferences and a host for prestigious surgical training programs, Dr. Blønd’s work continues to shape modern orthopedic surgery. His dedication to research, education, and surgical innovation reflects the qualities of an esteemed medical professional worthy of high honors.

Research Skill

Dr. Lars Blønd possesses exceptional research skills, demonstrated by his extensive contributions to orthopedic literature and surgical innovation. With over 40 peer-reviewed publications, multiple book chapters, and a leading role in developing Arthroscopic Deepening Trochleoplasty, he has established himself as a key researcher in patellofemoral instability and knee biomechanics. His ability to conduct high-quality clinical studies, retrospective analyses, and surgical technique evaluations showcases his expertise in evidence-based medicine. Dr. Blønd’s research skills extend to advanced imaging interpretation, biomechanical assessments, and regenerative medicine, particularly in the use of adipose-derived stem cells for osteoarthritis treatment. His involvement in international research collaborations, editorial contributions, and live surgical demonstrations further highlights his analytical and problem-solving abilities. As a frequent speaker at global conferences and an educator in arthroscopic surgery, he integrates research with clinical practice, continuously advancing the field of orthopedic surgery through data-driven insights and innovative surgical approaches.

Conclusion

Dr. Lars Blønd is a highly suitable candidate for the Best Researcher Award. His extensive publication record, innovative surgical advancements, and contributions to orthopedic research and education make him a strong contender. While he could further expand his research scope and collaborations, his impact on patellofemoral surgery and sports medicine is undeniable, making him an exemplary researcher in his field.

Publications Top Noted

  • Exercise performance in elite male and female sailors
    Authors: Larsson, B., Beyer, N., Bay, P., Blønd, L., Aagaard, P., and Kjaer, M.
    Year: 1996
    Citation: Int. J Sports Med. 17: 504-508

  • Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes
    Authors: Blønd, L. and Hansen, L.
    Year: 1998
    Citation: Acta Orthop Belg. 64: 393-400

  • Injuries caused by falling soccer goalposts in Denmark
    Authors: Blønd, L. and Hansen, L. B.
    Year: 1999
    Citation: Br. J Sports Med. 33: 110-112

  • Scintigraphic method for evaluation of reductions in local blood volumes in human extremities
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2000
    Citation: Scand J Lab Clin Inv. 60;(5): 333-339

  • Exsanguination of lower limbs before surgery
    Authors: Blønd, L., Kirketerp-Moeller K, Sonne-Holm S, and Madsen J.L.
    Year: 2002
    Citation: Acta Orthop Scand. 73;(1): 89-92

  • Exsanguination of upper limbs before surgery
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2002
    Citation: JBJS (Br). 84;(4):489-491

  • Exsanguination of limbs in elderly before surgery: A comparison with young individuals
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Int. Orthop. 27;(2): 114-116

  • Bone marrow perfusion in healthy subjects assessed by scintigraphy after application of a tourniquet
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(4): 460-464

  • Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty
    Authors: Husted H., Blønd L., Sonne-Holm S., Holm G., Jacobsen T., Gebuhr P.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(6): 665-669

  • Clinical Consequences of Different Exsanguination Methods in Hand Surgery: A Double-blind Randomised Study
    Authors: Blønd L., Jensen NV., Søe-Nielsen NH.
    Year: 2008
    Citation: Journal of Hand Surgery (European Volume) 33; 475

  • Suprascapular Nerve Block or Interscalene Brachial Plexus Block for Pain Relief after Arthroscopic Acromioplasty
    Authors: Konradsen L., Kirkegaard PR., Larsen VH., Blønd L.
    Year: 2009
    Citation: Ambulatory Surgery 15-1

  • The arthroscopic deepening trochleoplasty
    Authors: Blønd L. and Schöttle P.
    Year: 2010
    Citation: Knee Surg Sports Traumatol Arthrosc 18(4):480-5

  • Development in sports medicine
    Authors: Blønd L.
    Year: 2012
    Citation: Ugeskr Laeger 174(12):783

  • Arthroscopic treatment for snapping scapula: a prospective case series
    Authors: Blønd L., & Rechter S.
    Year: 2014
    Citation: Eur J Orthop Surg & Traumatol 24(2):159-64

  • Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament for patients with recurrent patella dislocation and trochlear dysplasia
    Authors: Blønd L., & Haugegaard M.
    Year: 2014
    Citation: Knee Surg Sports Traumatol Arthrosc 22:2484–2490